Displaying items 13-24 of 100
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
•
Next >
-
Swine flu activity continues to be low as WHO defends actions
Booster ShotsActivity of the pandemic H1N1 influenza virus continues to ebb in the United States, with no states reporting widespread flu activity in the week ending Jan. 23 and only five states reporting regional activity. Hospitalization rates have leveled off, and.... -
Be careful which Maalox you pick up, FDA says
Booster ShotsThe packages say Maalox Advanced and Maalox Total Relief, and consumers might justifiably think that they are simply two versions of the same product. But they are not, and mix-ups have resulted in at least five reports of serious adverse...... -
Drugs in pre-diabetics do little to slow progression to diabetes or to heart disease, study finds
Booster ShotsA combination of drugs that researchers hoped would delay progression to diabetes and/or heart disease in people with impaired glucose tolerance provided little benefit, researchers reported Sunday at an Atlanta meeting of the American College of... -
RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
ReutersBy Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...Tags: Hospitals and Clinics, Vaccines, Merck & Company Incorporated, Meningitis, Pharmaceuticals
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Vaccines, Amgen Inc., Medical Research, Weather, Science and Technology
-
Immune system cancer drugs tipped to be a $35 billion market
ReutersLONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...Tags: Vaccines, Amgen Inc., Medical Research, Weather, Science and Technology
-
Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales
ReutersPor Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...Tags: Amgen Inc., Citigroup Incorporated, Roche Holding AG, Merck & Company Incorporated, AstraZeneca Plc
-
Deals of the day -- mergers and acquisitions
ReutersMay 16 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** DDR Corp, owner of shopping centers where big-box retailers are located, said on Wednesday it had agreed to buy from Blackstone Group LP...Tags: BP Plc, Japan, Germany, Sprint Nextel Corporation, Austria
-
Novartis says has no intention of buying Actavis
ReutersZURICH, May 16 (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday. "We have no intention to pursue them," spokesman...Tags: The Wall Street Journal
-
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters* Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...Tags: Politics, Zurich (Swiss Confederation), Merck & Company Incorporated, Voting, Patents, Copyrights and Trademarks
-
Acciones europeas alcanzan máximo 5 años impulsadas por papeles suizos
ReutersPor Sudip Kar-Gupta LONDRES, 15 mayo (Reuters) - Las acciones europeas treparon el miércoles a nuevos máximos de cinco años, lideradas por los avances de papeles suizos tras un retroceso del franco suizo que debería continuar beneficiando a los... -
SEC says new settlements end 'Golden Goose' insider trading case
Reuters* Jamil Bouchareb, Daniel Corbin settle civil cases * Tips said to be misappropriated from PR firm executive May 15 (Reuters) - The U.S. Securities and Exchange Commission on Wednesday said it has reached settlements with the last two defendants in an...Tags: Electronic Arts Inc., Trials, Anheuser-Busch InBev, Insider Trading, Prisons
Jan 29, 2010
| Los Angeles Times
Feb 17, 2010
| Los Angeles Times
Mar 14, 2010
| Los Angeles Times
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
Original site for Novartis AG topic gallery.